Agata Hogendorf

Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties

Jakub Staroń, Rafał Kurczab, Dawid Warszycki et al. · European Journal of Medicinal Chemistry · 2019 · 37 citations · Full text

Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillers

Adam S. Hogendorf, Agata Hogendorf, Katarzyna Popiołek-Barczyk et al. · European Journal of Medicinal Chemistry · 2019 · 33 citations · Full text

Medicinal Chemistry, Health Sciences, Biochemistry +14

Search for a 5-CT alternative. <i>In vitro</i> and <i>in vivo</i> evaluation of novel pharmacological tools: 3-(1-alkyl-1<i>H</i>-imidazol-5-yl)-1<i>H</i>-indole-5-carboxamides, low-basicity 5-HT₇ receptor agonists

Gniewomir Latacz, Adam S. Hogendorf, Agata Hogendorf et al. · MedChemComm · 2018 · 30 citations · Full text

Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands – Fluoxetine and fluvoxamine

Jakub Staroń, Wojciech Pietruś, Ryszard Bugno et al. · European Journal of Medicinal Chemistry · 2021 · 29 citations · Full text

Halogenation, Molecular Pharmacology, Medicinal Chemistry +13

Low-basicity 5-HT7 Receptor Agonists Synthesized Using the van Leusen Multicomponent Protocol

Adam S. Hogendorf, Agata Hogendorf, Rafał Kurczab et al. · Scientific Reports · 2017 · 25 citations · Full text